Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells

References

• Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999;19:379–406.
   PubMed Web of Science ®Google Scholar
• Aiston S, Coghlan MP, Agius L. Inactivation of phosphorylase is a major component of the mechanism by which insulin stimulates hepatic glycogen synthesis. Eur J Biochem 2003;270:2773–81.
   PubMedGoogle Scholar
• Iynedjian PB, Jotterand D, Nouspikel T, Asfari M, Pilot PR. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J Biol Chem 1989;264:21824–9.
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 1988;37:15–21.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415–28.
   PubMed Web of Science ®Google Scholar
• Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli, AJ., et al.. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345–53.
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med 2005;37:347–56.
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Nurjhan N, Perriello G., Dailey G., Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:550–4.
   PubMed Web of Science ®Google Scholar
• Frayn KN. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 2002;11 Suppl 2:31–40.
   PubMedGoogle Scholar
• Steiner G, Morita S, Vranic M. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes 1980;29:899–905.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020–4.
   PubMed Web of Science ®Google Scholar
• Jucker BM, Rennings AJ, Cline GW, Shulman GI. 13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat. J Biol Chem 1997;272:10464–73.
   PubMedGoogle Scholar
• Nolte LA, Galuska D, Martin IK, Zierath JR, Wallberg-Henriksson H. Elevated free fatty acid levels inhibit glucose phosphorylation in slow-twitch rat skeletal muscle. Acta Physiol Scand 1994;151:51–9.
   PubMedGoogle Scholar
• Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al.. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996;97:2859–65.
   PubMed Web of Science ®Google Scholar
• Kelley DE, Mokan M, Simoneau JA, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993;92:91–8.
   PubMed Web of Science ®Google Scholar
• Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, et al. Effects of fast on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 1991;88:960–6.
   PubMed Web of Science ®Google Scholar
• Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93:2438–46.
   PubMed Web of Science ®Google Scholar
• Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, Ye JM. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes 2004;53:3258–66.
   PubMed Web of Science ®Google Scholar
• Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest 2002;110:1389–98.
   PubMed Web of Science ®Google Scholar
• Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol 2004;14:20–8.
   PubMed Web of Science ®Google Scholar
• Hampton RY. ER stress response: getting the UPR hand on misfolded proteins. Curr Biol 2000;10:R518–21.
   PubMed Web of Science ®Google Scholar
• Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000;101:451–4.
   PubMed Web of Science ®Google Scholar
• Harding HP, Calfon M, Urano F, Novoa I, Ron D. Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 2002;18:575–99.
   PubMed Web of Science ®Google Scholar
• Ma Y, Hendershot LM. The unfolding tale of the unfolded protein response. Cell 2001;107:827–30.
   PubMed Web of Science ®Google Scholar
• Kaufman RJ, Scheuner D, Schroder M, Shen X, Lee K, Liu CY, et al. The unfolded protein response in nutrient sensing and differentiation. Nat Rev Mol Cell Biol 2002;3:411–21.
   PubMed Web of Science ®Google Scholar
• Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004;145:5087–96.
   PubMed Web of Science ®Google Scholar
• Bailey CJ. Metformin and intestinal glucose handling. Diabetes Metab Rev 1995;11 Suppl 1:S23–32.
   PubMedGoogle Scholar
• Boyd K, Rogers C, Boreham C, Andrews WJ, Hadden DR. Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy. Diabetes Res 1992;19:69–76.
   PubMedGoogle Scholar
• DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 1991;73:1294–301.
   PubMed Web of Science ®Google Scholar
• Galuska D, Nolte LA, Zierath JR, Wallberg-Henriksson H. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia 1994;37:826–32.
   PubMedGoogle Scholar
• Jackson RA, Hawa MI, Jaspan JB, Sim BM, Disilvio L, Featherbe D, et al. Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes 1987;36:632–40.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Johnston P, Hollenbeck CB, Skowronski R, Zhang JC, Goldfine ID, et al.. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control. J Clin Endocrinol Metab 1992;74:1020–6.
   PubMed Web of Science ®Google Scholar
• Kim DS, Chae SW, Kim HR, Chae HJ. CO and bilirubin inhibit doxorubicin-induced cardiac cell death. Immunopharmacol Immunotoxicol 2009;31(1):64–70.
   PubMedGoogle Scholar
• Chae HJ, Jeong BJ, Ha MS, Lee JK, Byun JO, Jung WY, et al. R.ERK MAP Kinase is required in 1,25(OH)2D3-induced differentiation in human osteoblasts. Immunopharmacol Immunotoxicol 2002;24(1):31–41.
   PubMedGoogle Scholar
• Schroder M, Kaufman R.J. ER stress and the unfolded protein response. Mutat Res 2005;569:29–63.
   PubMed Web of Science ®Google Scholar
• Sanyal A. J, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling, RK. Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183–92.
   PubMed Web of Science ®Google Scholar
• Leekumjorn S, Wu Y, Sum AK, Chan C. Experimental and computational studies investigating trehalose protection of HepG2 cells from palmitate-induced toxicity. Biophys J 2008;94:2869–83.
   PubMedGoogle Scholar
• Lu J, Caplan MS, Li D, Jilling T. Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/AKT-mediated apoptosis in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008;294:G1181–90.
   PubMedGoogle Scholar
• Dhayal S, Welters HJ, Morgan NG.. Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11. Br J Pharmacol 2008;153:1718–27.
   PubMedGoogle Scholar
• Choi SE, Lee YJ, Jang HJ, Lee KW, Kim YS, Jun HS, et al. A chemical chaperone 4-PBA ameliorates palmitate-induced inhibition of glucose-stimulated insulin secretion (GSIS). Arch Biochem Biophys 2008;475:109–14.
   PubMed Web of Science ®Google Scholar
• Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, Takashima S, et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 2004;110:705–12.
   PubMed Web of Science ®Google Scholar
• Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 2002;7:335–45.
   PubMed Web of Science ®Google Scholar
• McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001;21:1249–59.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen D, Androlewicz MJ. The role of endoplasmic reticulum-associated protein degradation in MHC class I antigen processing. Immunol Rev 1999;172:67–72.
   PubMedGoogle Scholar
• Tzatsos A, Kandror KV. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 2006;26:63–76.
   PubMed Web of Science ®Google Scholar
• Mordier S, Iynedjian PB. Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes. Biochem Biophys Res Commun 2007;p362:206–11.
   PubMedGoogle Scholar
• Festa A, D’Agostino R Jr, Rich SS, Jenny NS, Tracy RP, Haffner SM. Promotor (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 2003;107:2422–7.
   PubMed Web of Science ®Google Scholar
• He L, Sabet A, Djedjos S, Miller R, Sun X, Hussain MA, et al. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 2009;15,137(4):635–46.
   Google Scholar
• Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M. Non-alcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844–50.
   PubMed Web of Science ®Google Scholar